Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Active Machine Learning In Drug Discovery Practical Considerations
Review Article: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000195
Anticancer Drug Protection in Neurodegenerative Disorders a Medication Repurposing Approach
Review Article: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000196
Classification of Cutaneous Sensitizers in Pharmaceutical Manufacturing
Short Communication: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000197
Drug Repurposing a Viable Tool for Speeding up Drug Discovery
Short Communication: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000198
Human Genetics and Network Biology for Advancing Next-Generation Drug Repurposing Techniques
Mini Review: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000199
Resistance to Antifungal Drugs Evolution, Causes, and Consequences
Short Communication: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000200
Understanding Multidrug Resistant Microorganisms in Intensive Care Units to Combat Resistance
Review Article: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000201
Enhancing Transdermal Medication Delivery Using Micro-Pillar Tunnel Stamps
Case Report: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000204
Case Report: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000202
Harnessing the Power of Targeted RNA Therapies for Cancer Treatment and Immunomodulation
Short Communication: J Pharmacokinet Exp Ther 2023, 7:5
DOI: 10.4172/jpet.1000203
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals